Arvinas, Inc. ARVN
NASDAQ · United States · Health Technology
$7.41-0.02 (-0.27%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 2.58 | -0.37 | +789.6% | $249.70M | +311.3% | +4.2%$8.06→$8.40 |
| Q1 2026 | 2026-05-11 | -0.90 | -0.96 | +6.2% | — | — | -5.3%$10.11→$9.57 |
| Q4 2025 | 2026-02-24 | -1.10 | -0.57 | -93.0% | — | — | +8.1%$12.30→$13.30 |
| Q3 2025 | 2025-11-05 | -0.48 | -0.75 | +36.0% | — | — | +4.8%$9.54→$10.00 |
| Q4 2024 | 2025-02-11 | -0.63 | -0.96 | +34.4% | — | — | — |
| Q2 2024 | 2024-07-30 | -0.49 | -0.59 | +16.9% | — | — | — |
| Q4 2023 | 2024-02-27 | -2.53 | -1.23 | -105.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.